Literature DB >> 25711059

[Oxidative stress in uveitis and its correction with superoxide dismutase antioxidative enzyme (experimental study)].

N B Chesnokova, V V Neroev, O V Beznos, G A Beĭshenova, I I Nikol'skaia, O A Kost, P V Binevskiĭ, A B Shekhter.   

Abstract

OBJECTIVE: to study the influence of experimental uveitis on those biochemical parameters of aqueous humor that reflect inflammation acuity as well as local antioxidant and local antiproteolytic activity; to study the effect of topical superoxide dismutase (SOD) on the clinical course of uveitis and ocular metabolism.
MATERIAL AND METHODS: Acute uveitis was induced in rabbits by a double injection (subcutaneous and intravitreal) of normal horse serum. The following parameters of aqueous humor were measured: protein concentration, antioxidant activity, SOD activity, alpha2-macroglobulin level, total nitrates and nitrites, and leukocyte number. Clinical assessment and histopathological study were performed.
RESULTS: It was found that uveitis is associated with a statistically significant increase in protein concentration, leukocyte number, SOD activity, and alpha2-macroglobulin level in aqueous humor as well as a decrease in anti-hydroxyl radical activity. SOD instillations contributed to the reduction of the listed parameters and improvement of the antioxidant activity. Clinical presentations of uveitis also became less pronounced.
CONCLUSION: SOD instillations for oxidative stress correction help reduce clinical presentations of uveitis, which is confirmed by biochemical examination.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25711059

Source DB:  PubMed          Journal:  Vestn Oftalmol        ISSN: 0042-465X


  1 in total

1.  Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.

Authors:  Olga A Kost; Olga V Beznos; Nina G Davydova; Devika S Manickam; Irina I Nikolskaya; Anna E Guller; Petr V Binevski; Natalia B Chesnokova; Anatoly B Shekhter; Natalia L Klyachko; Alexander V Kabanov
Journal:  Oxid Med Cell Longev       Date:  2015-12-01       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.